HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.31
-0.30 (-2.05%)
Dec 20, 2024, 4:00 PM EST - Market closed
HUTCHMED (China) Employees
HUTCHMED (China) had 1,988 employees as of December 31, 2023. The number of employees decreased by 37 or -1.83% compared to the previous year.
Employees
1,988
Change (1Y)
-37
Growth (1Y)
-1.83%
Revenue / Employee
$307,246
Profits / Employee
-$21,112
Market Cap
2.55B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Surgery Partners | 13,500 |
Concentra Group Holdings Parent | 9,020 |
Neogen | 2,917 |
LivaNova | 2,900 |
Twist Bioscience | 923 |
Arrowhead Pharmaceuticals | 609 |
SpringWorks Therapeutics | 305 |
Kymera Therapeutics | 187 |
HCM News
- 9 days ago - HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib) - GlobeNewsWire
- 10 days ago - HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients After Disease Progression on EGFR Inhibitor Therapy - GlobeNewsWire
- 18 days ago - Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer - PRNewsWire
- 18 days ago - HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer - GlobeNewsWire
- 23 days ago - HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms - GlobeNewsWire
- 4 weeks ago - HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan - GlobeNewsWire
- 4 weeks ago - HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee - GlobeNewsWire
- 6 weeks ago - HUTCHMED Highlights Clinical Data to be Presented at the 2024 ASH Annual Meeting and the 2024 ESMO Asia Congress - GlobeNewsWire